(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Atrial Fibrillation
This study will compare the safety and effectiveness of an investigational ablation catheter that uses light-energy to treat atrial fibrillation. Volunteers 18-65 who have failed to respond to drug treatment or find the side effects of standard medication intolerable may be eligible to participate.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat243.html.
-----
Osteoarthritis
Volunteers who have knee pain associated with osteoarthritis may qualify for this study of an investigational device. Volunteers 40-80 who have knee pain while standing or performing activity may be eligible.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat109.html.
-----
Multiple Sclerosis
This study for people with multiple sclerosis will evaluate the effects of an investigational drug on cognitive functions including memory and thinking skills. Participants will need to visit the study clinic approximately six times over a three-month period. Candidates 18-64 who have at least a 9th grade education and a diagnosis of MS (relapsing remitting or secondary progressive) may qualify.
The research sites are located across the United States.
More information
Please see http://www.centerwatch.com/patient/studies/cat102.html.
-----
Copyright 2007 Thomson CenterWatch. All rights reserved.
